Table 2.
ALIS + GBT | GBT alone | Adjusted odds ratio | |
---|---|---|---|
Total no. of patients (ITT population) | 224 | 112 | |
Patients with culture conversiona (%) | 65 (29.0*) | 10 (8.9) | 4.22 (95% CI 2.08–8.57) |
ALIS amikacin liposome inhalation suspension, GBT guidelines-based therapy, ITT intent-to-treat
*p < 0.001 vs. GBT alone
aCulture conversion defined as having three consecutive monthly Mycobacterium avium complex-negative sputum cultures by month 6